Orchestra BioMed Holdings (OBIO) Change in Account Payables (2021 - 2022)
Orchestra BioMed Holdings (OBIO) posted quarterly Change in Account Payables of $95369.0 for Q4 2022, up 35818.73% year-over-year from N/an in Q4 2021, and down 14.01% quarter-over-quarter from $110904.0 in Q3 2022.
Powered by 
Analysis
Orchestra BioMed Holdings (OBIO) Change in Account Payables (2021 - 2022) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Change in Account Payables for 2 consecutive years, with $95369.0 the latest figure, recorded in Q4 2022.
- In Q4 2022, Change in Account Payables rose 35818.73% year-over-year to $95369.0; the TTM figure through Dec 2022 stood at $375542.0 (up 3123.2% YoY), while the FY2022 annual figure was $375542.0, up 3123.2% from the prior year.
- Change in Account Payables declined to $95369.0 in Q4 2022 per OBIO's latest filing, from $110904.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $110904.0 in Q3 2022 and bottomed at -$17680.0 in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Orchestra BioMed Holdings | 322.25 Mn | 127.72 Mn | 63,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 95,369.00 |
| Sep 30, 2022 | 110,904.00 |
| Jun 30, 2022 | 67,050.00 |
| Mar 31, 2022 | 102,219.00 |
| Dec 31, 2021 | -267.00 |
| Sep 30, 2021 | -17,680.00 |
| Jun 30, 2021 | -15,225.00 |
| Mar 31, 2021 | 20,750.00 |